<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263064</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00091670</org_study_id>
    <nct_id>NCT04263064</nct_id>
  </id_info>
  <brief_title>High Volume Caudal Study</brief_title>
  <official_title>Effect of Clonidine on High Volume-Low Concentration Caudals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to evaluate the effect of clonidine on the duration of analgesia
      provided by a high volume-low concentration caudal block for pediatric aurgical procedres. In
      addition, caudal clonidine's effect on length of recovery and post-operative emergence
      agitation will be measured.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized, observer blinded study will attempt to determine if there is any benefit to the addition of clonidine to a HVLC caudal block, both in duration of analgesia and occurrence of emergence agitation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Outcome assessor and patient blinded to the medications in the block that the patient receives.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of Pain</measure>
    <time_frame>24 hours</time_frame>
    <description>The effect of clonidine on the duration of the analgesia provided by a high volume-low concentration caudal will be measured in the Post Anesthesia Care Unit pain assessments using CHEOPS score every at 0, 30, 60, and 90 minutes after arrival to PACU.
The CHEOPS pain score tool is an observational scale for measuring postoperative pain in children aged 1-7 yrs. The tool includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Administration of Rescue Pain Medications</measure>
    <time_frame>24 hours</time_frame>
    <description>Data will be collected and analyzed on the need for rescue pain medications by collecting doses of opioids administered the Post Anesthesia Care Unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to first Administration of Acetaminophen</measure>
    <time_frame>24 hours</time_frame>
    <description>24 hours after discharge a phone call interview will be conducted to obtain the time of the first dose of acetaminophen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic Changes</measure>
    <time_frame>24 hours</time_frame>
    <description>A change of greater than 20% in heart rate or blood pressure from their baseline established in the preoperative area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Emergence Delirium</measure>
    <time_frame>24 hours</time_frame>
    <description>The incidence of emergence delirium will be collected utilizing the PAED Scale at 0, 30, 60, and 90 minutes after arrival to the Post Anesthesia Care Unit. The PAED scale will measure the presence of delirium by scoring behaviors from 1-4 (1=calm, 2=not calm but consolable, 3=moderately agitate, restless or not easily calmed, 4=combative, excited, thrashing around)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation Levels</measure>
    <time_frame>24 hours</time_frame>
    <description>Measured in PACU utilizing Ramsay Sedation Scale at 0, 30, 60, and 90 minutes after arrival in PACU. The Ramsay sedation scale is a scoring of responses (1-6) [1=anxious or restless, 2=cooperative, oriented, tranquil, 3=responding to commands, 4=brisk response to stimulus, 5=sluggish response to stimulus, 6=no response to stimulus].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Time to Discharge</measure>
    <time_frame>24 hours</time_frame>
    <description>time of arrival to PACU and discharge time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Male Circumcision</condition>
  <arm_group>
    <arm_group_label>High Volume-Low Concentration without Clonidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control for this study will be a High Volume-Low Concentration (1.5cc/kg of 0.15% ropivacaine and 5mcg/cc epinephrine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Volume-Low Concentration with clonidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study intervention will be High Volume-Low Concentration with clonidine (1.5cc/kg of 0.15% ropivacaine, with 1mcg/cc of clonidine and 5mcg/cc epinephrine).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High Volume-Low Concentration without Clonidine</intervention_name>
    <description>The control for this study will be a High Volume-Low Concentration (1.5cc/kg of 0.15% ropivacaine and 5mcg/cc epinephrine) caudal block</description>
    <arm_group_label>High Volume-Low Concentration without Clonidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High Volume-Low Concentration with clonidine</intervention_name>
    <description>The study intervention will be High Volume-Low Concentration with clonidine (1.5cc/kg of 0.15% ropivacaine, with 1mcg/cc of clonidine and 5mcg/cc epinephrine).</description>
    <arm_group_label>High Volume-Low Concentration with clonidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  3 years old or less

          -  Weight &lt;= 13.3kg

          -  American Society of Anesthesiology Physical Status (ASA) 1 or 2

          -  Undergoing circumcision surgery

          -  Patients whose plan of care includes caudal block

        Exclusion Criteria:

          -  Known allergy to clonidine, epinephrine, or amide local anesthetics

          -  Inability or unwillingness of parent or legal guardian to give informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>presenting for penile circumcision</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Heine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher Heine, MD</last_name>
    <phone>(843) 792-5035</phone>
    <email>heinec@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wanda Jones, BSN</last_name>
    <phone>843-792-1869</phone>
    <email>joneswr@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Jones, BSN, RN</last_name>
      <phone>843-792-1869</phone>
      <email>joneswr@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Heine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 1, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>March 11, 2020</last_update_submitted>
  <last_update_submitted_qc>March 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Christopher Heine, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

